Nice

New Post Public Reply Private Reply Replies (0) Message Board
joey68 bobobwilly #8
Nice find

https://www.sec.gov/Archives/edgar/data/14319...142016.htm

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arbor Scientia Snags Second Consecutive BASA Win

Updated Category News Views 9

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

Continue Reading
Cecilia Vicuña's Bold Exhibition at MOCA Tackles Water Crisis

Updated Category News Views 0

Art and ecological awareness dance together on a tightrope at the Museum of Contemporary Art (MOCA) in Los Angeles. Cecilia Vicuña’s new exhibition, The Dream of Water: Quipu of Encounters Maricunga, arrives with a punch, not merely as art but as a call to arms for water conservation and environmental justice. The show kicks off on November 15, 2026, and remains open...

Continue Reading
Primoris Faces Allegations Over Misleading Project Costs

Updated Category News Views 0

Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....

Continue Reading
AHN Opens Clinic for Severe Postpartum Tear Care

Updated Category News Views 4

A Game Changer for Postpartum Recovery When it comes to childbirth, you think you've heard it all, but here's a twist—Allegheny Health Network (AHN) just swung the doors open on a clinic laser-focused on a very raw deal: third- and fourth-degree perineal lacerations. We're diving into new territory where one network sees the gap and jumps into action, calling in the...

Continue Reading
Ademi LLP Investigates Braze Buyout Concerns for Investors

Updated Category News Views 3

Scrutinizing Braze's $5.66 Billion Salesforce Deal There's a shake-up brewing in the world of tech buyouts, and it's hitting home with Braze, Inc. (NASDAQ: BRZE). On the surface, a $47.50 per share all-cash offer from Salesforce might look like a shiny deal, totalling up to a robust $5.66 billion valuation. However, Ademi LLP, a law firm no stranger to corporate scrutiny,...

Continue Reading
Prosecco DOC Chef Residency Debriefs on Inaugural Year

Updated Category News Views 2

A Fusion of Flavors: The Residency Recap Alright, listen up. The Prosecco DOC Chef Residency has wrapped its initial bash in Italy, where it played culinary matchmaker with talents from Brazil, South Korea, Canada, and the UK. Picture some top-notch chefs crossing borders and tweaking recipes with that unique Italian spark of Prosecco DOC. It wasn't just some ballroom...

Continue Reading
ALS.Community Launches Free Online Support Platform

Updated Category News Views 11

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Continue Reading
Harry Ritchie's Marks 70th Anniversary with Charity Event

Updated Category News Views 1

You don't sniff 70 years in retail without sewing some sturdy community threads. Harry Ritchie's, a stalwart in Eugene, Oregon's retail scene, just pulled a classic move: celebrating their seven-decade milestone by feeding folks instead of throwing a gala. In a world where local shops often vanish like ghosts, they're sticking with the founder's mantra from 1956: Be...

Continue Reading
Life After Debt: Freedom, Confidence, and Wellbeing

Updated Category News Views 6

The Unseen Upside of Financial Freedom Debt can feel like a ball and chain, dragging down everything from your sleep to your relationships. But shred that debt, and suddenly the world looks different. Accredited Debt Relief's recent survey of 1,000 folks who've paid off at least $5,000 in unsecured debt uncovers the remarkable transformations that follow. According to 93%...

Continue Reading
Innventure Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 0

Legal Troubles Mount for Innventure, Inc. Looks like Innventure, Inc. is caught in the kind of mess that even seasoned traders dread—a class action lawsuit hanging over its head like a storm cloud just bursting with lightning. If you're holding a piece of Innventure (NASDAQ: INV), this is one of those times when you've got to look your portfolio straight in the eye and...

Continue Reading

Top 5 Most Recently Viewed Articles

Kornit Digital Leads The Shift to On-Demand Fashion Solutions

Updated Category News Views 72

Kornit Digital Leads the Shift to On?Demand Fashion Kornit Digital LTD. (NASDAQ: KRNT) is pushing the textile world deeper into digital with a clear, practical message: make only what you need, when you need it. At its “Fashion is Choosing On-Demand” event, held alongside PRINTING United Expo 2024, the company put that idea on stage—showing how its technology turns...

Continue Reading
Navigating Business Transitions with ExitWell Advisors

Updated Category News Views 176

Driving Strategic Business Transitions with Expertise ExitWell Advisors is making a significant impact in guiding business owners through the complexities of exit planning and transitions. Founded by the experienced business leader Dave Lokos, the firm focuses on helping owners take control of their future with thoughtful planning and readiness for transactions. With...

Continue Reading
Essential Safety Warnings Issued by the CPSC

Updated Category News Views 91

Safety Alerts from the CPSC In an ongoing effort to protect consumers, the U.S. Consumer Product Safety Commission (CPSC) has announced several alarming safety warnings regarding various products well-known in households today. The CPSC aims to keep families safe from potential dangers associated with consumer products. These warnings reflect a commitment to consumer...

Continue Reading
Denali Therapeutics Shares Promising Results in Hunter Syndrome Study

Updated Category News Views 172

Denali Therapeutics Reveals Phase 1/2 Study Insights Denali Therapeutics Inc. (NASDAQ: DNLI) has recently shared exciting updates from the primary analysis of its Phase 1/2 study investigating tividenofusp alfa (DNL310) for treating Hunter syndrome, also known as MPS II. Conducted with 47 participants during a 24-week treatment phase, this clinical trial has yielded...

Continue Reading
The Future of Autonomous Last Mile Delivery: Market Insights

Updated Category News Views 263

Overview of the Autonomous Last Mile Delivery Market The global autonomous last mile delivery market is experiencing rapid growth, anticipating a value of US$ 185.30 billion by 2033. This signifies a substantial leap from the US$ 30.05 billion valuation in 2024, with a remarkable compound annual growth rate (CAGR) of 22.4%. The increasing demand for efficient logistics...

Continue Reading